Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30391714 | 1.00 | TSHR (0.35) | TSHRLMNACYP3A4TDP1CYP2A6 | |
| SCHEMBL7602941 | 0.81 | TSHR (0.50) | TSHRLMNACYP2A6CYP1A2 | |
| SCHEMBL10706514 | 0.81 | TSHR (0.50) | TSHRLMNACYP2A6CYP1A2 | |
| SCHEMBL1041344 | 0.78 | ACHE (0.38) | — | |
| SCHEMBL31536312 | 0.78 | ALDH1A1 (0.38) | TDP1 | |
| SCHEMBL258502 | 0.78 | TSHR (0.47) | TSHRLMNACYP3A4TDP1CYP2A6 | |
| Hydrochloric Acid SCHEMBL15845273 | 0.76 | TSHR (0.45) | TSHRLMNACYP3A4TDP1CYP2A6 | |
| SCHEMBL2879307 | 0.74 | CYP2A6 (0.48) | TDP1CYP2A6CYP1A2 | |
| SCHEMBL2368837 | 0.74 | CYP1A2 (0.48) | TSHRCYP3A4TDP1CYP2A6CYP1A2 | |
| SCHEMBL3937434 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-12291489-B2 | Synthesis of nanocomposites and their use in enhancing plant nutrition | WASHINGTON UNIVERSITY (US) | 2025-05-06 | — | — | US | disclosed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-09 | — | — | US | disclosed |
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10919031-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-29 | — | — | US | disclosed |
| US-10702861-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-07-07 | — | — | US | disclosed |
| EP-1593432-A2 | Polymer-supported phosphorus ligands for catalysis | E.I. du Pont de Nemours and Company (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-1593431-A2 | Polymer-supported phosphorus ligands for catalysis | E. I. du Pont de Nemours and Company (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-1593430-A2 | Polymer-Supported phosphorus ligands for catalysts | E.I. DU PONT DE NEMOURS & COMPANY INCORPORATED (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2005056566-A2 | METHOD FOR PRODUCING ORTHOMETALATED AND ORTHOSUBSTITUTED AROMATIC COMPOUNDS | SOLVIAS AG (CH) | 2005-06-23 | — | — | WO | disclosed |
| US-20030228629-A1 | Polymer-supported phosphorus ligands for catalysts | FAGAN PAUL J (US) | 2003-12-11 | — | — | US | disclosed |
| US-6630604-B1 | Phosphine and phosphine oxide ligands are prepared using polymeric supports. These compounds can be easily cleaved from the support, and along with the corresponding supported compounds, used as ligands in the preparation of novel, | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-10-07 | — | — | US | disclosed |
| US-20030104476-A1 | Polymer-supported phosphorus ligands for catalysis | FAGAN PAUL J (US) | 2003-06-05 | — | — | US | disclosed |
| EP-1133357-A2 | POLYMER-SUPPORTED PHOSPHORUS LIGANDS FOR CATALYSIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000021663-A2 | POLYMER-SUPPORTED PHOSPHORUS LIGANDS FOR CATALYSIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TSHR 4279/4885LMNA 3488/4885CYP3A4 1092/4885 |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TSHR 4279/4885LMNA 3488/4885CYP3A4 1092/4885 |
| US-20030228629-A1 | Polymer-supported phosphorus ligands for catalysts | PHOSPHO1, PSPH, PNKP | TSHR 4266/4885LMNA 2958/4885CYP3A4 4154/4885 |
| US-10919031-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | TSHR 4279/4885LMNA 3488/4885CYP3A4 1092/4885 |
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | TSHR 4123/4885LMNA 3103/4885CYP3A4 2079/4885 |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | TSHR 4711/4885LMNA 726/4885CYP3A4 4371/4885 |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TSHR 4279/4885LMNA 3488/4885CYP3A4 1092/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | TSHR 4245/4885LMNA 1039/4885CYP3A4 4442/4885 |
| US-10702861-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | TSHR 4279/4885LMNA 3488/4885CYP3A4 1092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.